GoAI
Get started
Amvis Holdings, Inc. logo

Amvis Holdings, Inc.

7071.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥427

−¥5.00 · -1.16%

Aug 24, 3:30 PM JST

7071.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Amvis Holdings, Inc. is a Japanese firm that delivers a wide array of care services. These offerings encompass residential nursing facilities, at-home nursing and general care, as well as various support programs for individuals with disabilities. Furthermore, the company provides consulting and other complementary services. Founded in 2013, Amvis Holdings maintains its headquarters in Tokyo, Japan.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Keiichi Shibahara
Listed since
Oct 9, 2019
Employees
5,135

Market position

Volume
382.7K
0.92× average
Average volume
413.95K
Average daily volume
Market cap
41.89B JPY
Beta
0.74
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
88.05B JPY
P/E (TTM)
13.26×
P/B (TTM)
1.09×
P/S (TTM)
0.82×
EV / EBITDA
9.76×
Earnings yield
6.23%
Free cash flow yield
-7.46%
Dividend yield
0.94%

Profitability & efficiency

Gross margin
26.83%
Operating margin
10.63%
Net margin
6.16%
Return on equity
10.13%
Return on assets
4.35%
Return on invested capital
5.13%

Financial health

Debt / equity
0.87×
Current ratio
1.12×
Altman Z-score
2.05
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends45%32%18%4%Gross margin, FY2021: 41.03%Gross margin, FY2022: 41.90%Gross margin, FY2023: 41.44%Gross margin, FY2024: 40.15%Gross margin, FY2025: 30.07%Operating margin, FY2021: 24.63%Operating margin, FY2022: 26.50%Operating margin, FY2023: 26.94%Operating margin, FY2024: 24.97%Operating margin, FY2025: 12.54%Net margin, FY2021: 17.13%Net margin, FY2022: 18.55%Net margin, FY2023: 19.73%Net margin, FY2024: 17.51%Net margin, FY2025: 7.44%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 41.03%. Gross margin FY2022 41.90%. Gross margin FY2023 41.44%. Gross margin FY2024 40.15%. Gross margin FY2025 30.07%. Operating margin FY2021 24.63%. Operating margin FY2022 26.50%. Operating margin FY2023 26.94%. Operating margin FY2024 24.97%. Operating margin FY2025 12.54%. Net margin FY2021 17.13%. Net margin FY2022 18.55%. Net margin FY2023 19.73%. Net margin FY2024 17.51%. Net margin FY2025 7.44%.

Income trends

Revenue

49.17B JPY+15.77%

Operating income

6.17B JPY-41.88%

Net income

3.66B JPY-50.79%
Income trends across reported periods53.83B JPY35.21B JPY16.59B JPY−2.03B JPYRevenue, FY2021: 15.33B JPYRevenue, FY2022: 23.07B JPYRevenue, FY2023: 31.99B JPYRevenue, FY2024: 42.48B JPYRevenue, FY2025: 49.17B JPYOperating income, FY2021: 3.78B JPYOperating income, FY2022: 6.11B JPYOperating income, FY2023: 8.62B JPYOperating income, FY2024: 10.61B JPYOperating income, FY2025: 6.17B JPYNet income, FY2021: 2.63B JPYNet income, FY2022: 4.28B JPYNet income, FY2023: 6.31B JPYNet income, FY2024: 7.44B JPYNet income, FY2025: 3.66B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 15.33B JPY. Revenue FY2022 23.07B JPY. Revenue FY2023 31.99B JPY. Revenue FY2024 42.48B JPY. Revenue FY2025 49.17B JPY. Operating income FY2021 3.78B JPY. Operating income FY2022 6.11B JPY. Operating income FY2023 8.62B JPY. Operating income FY2024 10.61B JPY. Operating income FY2025 6.17B JPY. Net income FY2021 2.63B JPY. Net income FY2022 4.28B JPY. Net income FY2023 6.31B JPY. Net income FY2024 7.44B JPY. Net income FY2025 3.66B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue49.17B JPY42.48B JPY31.99B JPY23.07B JPY15.33B JPY
Cost of goods sold34.39B JPY25.42B JPY18.73B JPY13.41B JPY9.04B JPY
Gross profit14.79B JPY17.05B JPY13.26B JPY9.67B JPY6.29B JPY
Selling, general, and administrative7.75B JPY5.85B JPY4.2B JPY3.21B JPY2.26B JPY
Operating expenses8.62B JPY6.45B JPY4.64B JPY3.55B JPY2.51B JPY
Interest expense563M JPY359M JPY230M JPY210M JPY151M JPY
Depreciation and amortization2.77B JPY1.85B JPY1.22B JPY854M JPY561M JPY
Operating income6.17B JPY10.61B JPY8.62B JPY6.11B JPY3.78B JPY
Net income3.66B JPY7.44B JPY6.31B JPY4.28B JPY2.63B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
37.51
FY2025 · -50.52% year over year
Latest fiscal-year revenue
49.17B JPY
FY2025 · +15.77% year over year
Next fiscal-year EPS consensus
25
FY2026 · 4 analysts
Next fiscal-year revenue consensus
50.63B JPY
FY2026 · 4 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend81.4458.9136.3813.85FY21FY22FY23FY24FY25FY26FY27FY28

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend66.68B48.01B29.34B10.67BFY21FY22FY23FY24FY25FY26FY27FY28

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥4.00

2025 complete year+77.8% since 2021

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥4.00

Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

Dividend

Ex-dividend Sep 29, 2025

¥4.00

Annual

Record Sep 30, 2025 · Payment Dec 22, 2025

Dividend

Ex-dividend Sep 27, 2024

¥4.00

Annual

Record Sep 30, 2024 · Payment Dec 23, 2024

Dividend

Ex-dividend Sep 28, 2023

¥3.00

Annual

Record Sep 30, 2023 · Payment Dec 25, 2023

Dividend

Ex-dividend Sep 29, 2022

¥6.00

Annual

Record Sep 30, 2022 · Payment Dec 26, 2022

Dividend

Ex-dividend Sep 29, 2021

¥9.00

Annual

Record Sep 30, 2021 · Payment Dec 27, 2021

7071.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,973

-0.54%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,815

+0.88%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,975

+0.32%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406

+0.80%

Continue in GoAI

Research 7071.T

research.disclaimer